CXCL8 enhances the angiogenic activity of umbilical cord blood-derived outgrowth endothelial cells in vitro

Cell Biology International

Volumn 35, Issue 3, 2011, Pages 201-208

  Kimura, Takashi ^a   Kohno, Hirao ^a   Matsuoka, Yoshikazu ^a   Murakami, Mari ^a   Nakatsuka, Ryusuke ^a   Hase, Makoto ^a   Yasuda, Katsuhiko ^a   Uemura, Yasushi ^a   Sasaki, Yutaka ^a   Fukuhara, Shirou ^a   Sonoda, Yoshiaki ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

CXCL8; CXCR2; Outgrowth endothelial cell; Transwell migration assay; Tube formation assay; Vasculogenesis

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; OUTGROWTH ENDOTHELIAL CELL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ANTIBODIES; CELL MOVEMENT; ENDOTHELIAL CELLS; FETAL BLOOD; HUMANS; INTERLEUKIN-8; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B;

ANIMALIA;

EID: 79251495092     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090225     Document Type: Article

References (32)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis.Science 1997;275:964-7.
2. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-72.
3. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004;287:C572-9.
4. Devalaraja RM, Nanney LB, Qian Q, Du J, Yu Y, Devalaraja MN et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000;115:234-44.
5. Duan H-X, Cheng L-M, Jian-Wang, Hu L-S, Lu G-X. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol Int 2006;30:1018-27.
6. He T, Peterson TE, Katusic ZS. Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. Am J Physiol Heart Circ Physiol 2005;289:968-72.
7. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003;278:8508-15.
8. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007;100:590-7.
9. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-93.
10. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-7.
11. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan S-D, Anderson M et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994;93:1564-70.
12. Keeley EC, Mehrad B, Strieter RM. Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 2008;28:1928-36.
13. - severe combined immunodeficiencyrepopulating cells by intra-bone marrow injection. Stem Cells 2007;25:1348-55.
14. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM et al. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 1992;258:1798-801.
15. Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 2006;40:455-64.
16. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995;95:89-103.
17. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-33.
18. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-76.
19. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005;8:63-71.
20. Murdoch C, Monk PN, Finn A. CXC chemokine receptor expression on human endothelial cells. Cytokine 1999;11:704-12.
21. Petzelbauer P., Watson CA, Pfau SE, Pober JS. IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995;7:267-72.
22. Ramjeesingh R, Leung R, Siu CH. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J 2003;17:1292-4.
23. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
24. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells umbilical vein endothelial cells. FASEB J 2000;14:2055-64.
25. Smadja DM, Bie' che I, Susen S, Mauge L, Laurendeau I, d'Audigier C et al. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. J Cell Mol Med, 2008;13(8B):2534-46.
26. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J et al. The functional role of the ELR motif in CXC chemokinemediated angiogenesis. J Biol Chem 1995;270:27348-57.
27. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow derived endothelial progenitor cells for neovascularization. Nature Med 1999;5:434-8.
28. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-6.
29. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-53.
30. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y et al. SCIDrepopulating cell activity of human cord blood-derived CD34-negative cells assured by intra-bonemarrow injection. Blood 2003;101:2924-31.
31. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-9.
32. Yoon C-H, Hur J, Park K-W, Kim J-H, Lee C-S, Oh I-Y et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells. The role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-27.